Clinical Trial Update: A Pharmacokinetic Study of Paliperidone ER [Phase 4]

View source ↗

Summary

A Phase 4 pharmacokinetic study of Paliperidone ER for schizophrenia and schizoaffective disorder, sponsored by National Taiwan University Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Paliperidone ER (Invega ER) (paliperidone extended-release)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: UNKNOWN